Zytiga (Abiraterone Acetate) in Kenya: Product Description

Product Overview

Zytiga (Abiraterone Acetate 250mg) is a prescription androgen biosynthesis inhibitor used to treat metastatic castration-resistant prostate cancer (mCRPC). It works by blocking the CYP17 enzyme, reducing testosterone production in the body (including adrenal glands and tumors), slowing cancer progression. In Kenya, Zytiga is a critical therapy for advanced prostate cancer, available in specialized oncology centers and select pharmacies.

Key Benefits:

• Extends survival in mCRPC patients.
• Used alongside prednisone to reduce side effects.
• Effective when hormone therapy or chemotherapy fails.

Frequently Asked Questions (FAQs)

1. What is Zytiga used for?

   • Treats metastatic prostate cancer that has stopped responding to standard hormone therapy (castration-resistant).
   • Also used for high-risk metastatic castration-sensitive prostate cancer (mCSPC).

2. Is Zytiga available in Kenya?

   • Yes, stocked in major cancer centers (e.g., Nairobi Hospital, Aga Khan University Hospital) and select pharmacies. Requires an oncologist’s prescription.

3. How much does Zytiga cost in Kenya?

   • High-cost medication (approx. KES 150,000–200,000 per 120-tablet pack). Check NHIF coverage or patient assistance programs (e.g., Janssen Compass).

4. Can Zytiga cure prostate cancer?

   • No. It controls progression and extends survival but is not a cure.

5. What are common side effects?

   • Mild: Joint swelling, fatigue, hot flashes, diarrhea.
   • Severe (seek help): Liver toxicity (yellowing skin, dark urine), high blood pressure, low potassium, or adrenal problems.

How to Use Zytiga

• Dosage:

  • Standard: 1,000mg daily (four 250mg tablets taken once daily).
  • Combination: Always taken with prednisone 5mg twice daily to reduce side effects.
  • Critical: Take on an empty stomach (1 hour before or 2 hours after meals). Food increases drug absorption, raising toxicity risks.

• Missed Dose:

  • Skip the missed dose if within 12 hours of the next dose. Do not double up.

• Precautions:

  • Liver Monitoring: Blood tests required every 2 weeks for the first 3 months.
  • Avoid Grapefruit: Increases drug levels in blood.
  • Pregnancy Warning: Men should use condoms; women should not handle crushed tablets.

Composition

• Active Ingredient: Abiraterone Acetate (250mg per tablet).
• Inactive Ingredients: Lactose monohydrate, microcrystalline cellulose, croscarmellose sodium, povidone, magnesium stearate.
• Packaging: 120 tablets (30-day supply) in bottles.

Conclusion

Zytiga is a life-extending therapy for Kenyan men battling advanced prostate cancer, offering hope when other treatments fail. Its unique mechanism of blocking testosterone production at multiple sources makes it highly effective, but strict adherence to dosing (especially fasting requirements) and regular monitoring are non-negotiable for safety.

Access & Affordability:

• Purchase from licensed oncology pharmacies (e.g., Medsafes, Pharmanova) with a prescription.
• Explore NHIF coverage (under specialized oncology packages) or manufacturer assistance programs.
• Discuss generic alternatives (e.g., Abirapro) with your oncologist for cost savings.

Disclaimer: This is not medical advice. Consult an oncologist before starting Zytiga.